nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCC2—Sulfasalazine—ankylosing spondylitis	0.239	0.291	CbGbCtD
Levetiracetam—ABCC2—Dexamethasone—ankylosing spondylitis	0.119	0.145	CbGbCtD
Levetiracetam—ABCB1—Methylprednisolone—ankylosing spondylitis	0.103	0.125	CbGbCtD
Levetiracetam—ABCC2—Methotrexate—ankylosing spondylitis	0.0958	0.117	CbGbCtD
Levetiracetam—ABCB1—Betamethasone—ankylosing spondylitis	0.0668	0.0813	CbGbCtD
Levetiracetam—ABCB1—Prednisolone—ankylosing spondylitis	0.0659	0.0802	CbGbCtD
Levetiracetam—ABCB1—Prednisone—ankylosing spondylitis	0.0623	0.0758	CbGbCtD
Levetiracetam—ABCB1—Dexamethasone—ankylosing spondylitis	0.0389	0.0473	CbGbCtD
Levetiracetam—ABCB1—Methotrexate—ankylosing spondylitis	0.0312	0.038	CbGbCtD
Levetiracetam—SV2A—Uptake and actions of bacterial toxins—ANTXR2—ankylosing spondylitis	0.0241	0.849	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ANTXR2—ankylosing spondylitis	0.000983	0.0347	CbGpPWpGaD
Levetiracetam—SV2A—Disease—B3GNT2—ankylosing spondylitis	0.000579	0.0204	CbGpPWpGaD
Levetiracetam—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.000439	0.00293	CcSEcCtD
Levetiracetam—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000439	0.00293	CcSEcCtD
Levetiracetam—Lethargy—Methotrexate—ankylosing spondylitis	0.000436	0.00291	CcSEcCtD
Levetiracetam—Pancreatitis—Prednisone—ankylosing spondylitis	0.000433	0.00289	CcSEcCtD
Levetiracetam—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000417	0.00278	CcSEcCtD
Levetiracetam—Neutropenia—Prednisone—ankylosing spondylitis	0.000413	0.00276	CcSEcCtD
Levetiracetam—Irritability—Methotrexate—ankylosing spondylitis	0.000407	0.00272	CcSEcCtD
Levetiracetam—Mood swings—Methotrexate—ankylosing spondylitis	0.000404	0.0027	CcSEcCtD
Levetiracetam—Hallucination—Dexamethasone—ankylosing spondylitis	0.000404	0.0027	CcSEcCtD
Levetiracetam—Hallucination—Betamethasone—ankylosing spondylitis	0.000404	0.0027	CcSEcCtD
Levetiracetam—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000403	0.00269	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000402	0.00269	CcSEcCtD
Levetiracetam—Weight increased—Prednisone—ankylosing spondylitis	0.000402	0.00268	CcSEcCtD
Levetiracetam—Ataxia—Methotrexate—ankylosing spondylitis	0.000401	0.00268	CcSEcCtD
Levetiracetam—Weight decreased—Prednisone—ankylosing spondylitis	0.000399	0.00267	CcSEcCtD
Levetiracetam—Vision blurred—Prednisolone—ankylosing spondylitis	0.000399	0.00266	CcSEcCtD
Levetiracetam—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.000394	0.00263	CcSEcCtD
Levetiracetam—Depression—Prednisone—ankylosing spondylitis	0.000393	0.00262	CcSEcCtD
Levetiracetam—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000391	0.00261	CcSEcCtD
Levetiracetam—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000388	0.00259	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000384	0.00257	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000384	0.0136	CbGpPWpGaD
Levetiracetam—Vertigo—Prednisolone—ankylosing spondylitis	0.00038	0.00254	CcSEcCtD
Levetiracetam—Eye disorder—Betamethasone—ankylosing spondylitis	0.000379	0.00253	CcSEcCtD
Levetiracetam—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000379	0.00253	CcSEcCtD
Levetiracetam—Back pain—Triamcinolone—ankylosing spondylitis	0.000377	0.00251	CcSEcCtD
Levetiracetam—Asthma—Methotrexate—ankylosing spondylitis	0.000369	0.00246	CcSEcCtD
Levetiracetam—Convulsion—Prednisolone—ankylosing spondylitis	0.000367	0.00245	CcSEcCtD
Levetiracetam—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000365	0.00244	CcSEcCtD
Levetiracetam—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000362	0.00242	CcSEcCtD
Levetiracetam—Alopecia—Dexamethasone—ankylosing spondylitis	0.000359	0.00239	CcSEcCtD
Levetiracetam—Alopecia—Betamethasone—ankylosing spondylitis	0.000359	0.00239	CcSEcCtD
Levetiracetam—Hallucination—Prednisone—ankylosing spondylitis	0.000352	0.00235	CcSEcCtD
Levetiracetam—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00035	0.00234	CcSEcCtD
Levetiracetam—Vertigo—Triamcinolone—ankylosing spondylitis	0.00035	0.00234	CcSEcCtD
Levetiracetam—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000349	0.00233	CcSEcCtD
Levetiracetam—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000347	0.00232	CcSEcCtD
Levetiracetam—Neutropenia—Methotrexate—ankylosing spondylitis	0.000345	0.0023	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000343	0.00229	CcSEcCtD
Levetiracetam—Cough—Triamcinolone—ankylosing spondylitis	0.00034	0.00227	CcSEcCtD
Levetiracetam—Convulsion—Triamcinolone—ankylosing spondylitis	0.000337	0.00225	CcSEcCtD
Levetiracetam—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000337	0.00225	CcSEcCtD
Levetiracetam—Myalgia—Triamcinolone—ankylosing spondylitis	0.000331	0.00221	CcSEcCtD
Levetiracetam—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000331	0.00221	CcSEcCtD
Levetiracetam—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000331	0.00221	CcSEcCtD
Levetiracetam—Eye disorder—Prednisone—ankylosing spondylitis	0.00033	0.00221	CcSEcCtD
Levetiracetam—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00033	0.0022	CcSEcCtD
Levetiracetam—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000329	0.0022	CcSEcCtD
Levetiracetam—Infestation—Methotrexate—ankylosing spondylitis	0.000329	0.0022	CcSEcCtD
Levetiracetam—Drowsiness—Methotrexate—ankylosing spondylitis	0.000329	0.0022	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000328	0.00219	CcSEcCtD
Levetiracetam—Depression—Methotrexate—ankylosing spondylitis	0.000328	0.00219	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000326	0.00218	CcSEcCtD
Levetiracetam—Stomatitis—Methotrexate—ankylosing spondylitis	0.000321	0.00214	CcSEcCtD
Levetiracetam—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00032	0.00214	CcSEcCtD
Levetiracetam—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00032	0.00213	CcSEcCtD
Levetiracetam—Immune system disorder—Prednisone—ankylosing spondylitis	0.000319	0.00213	CcSEcCtD
Levetiracetam—Vertigo—Dexamethasone—ankylosing spondylitis	0.000317	0.00212	CcSEcCtD
Levetiracetam—Vertigo—Betamethasone—ankylosing spondylitis	0.000317	0.00212	CcSEcCtD
Levetiracetam—Infection—Triamcinolone—ankylosing spondylitis	0.000316	0.00211	CcSEcCtD
Levetiracetam—Infection—Methylprednisolone—ankylosing spondylitis	0.000315	0.0021	CcSEcCtD
Levetiracetam—Insomnia—Prednisolone—ankylosing spondylitis	0.000313	0.00209	CcSEcCtD
Levetiracetam—Alopecia—Prednisone—ankylosing spondylitis	0.000312	0.00209	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000311	0.00208	CcSEcCtD
Levetiracetam—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000311	0.00208	CcSEcCtD
Levetiracetam—Epistaxis—Methotrexate—ankylosing spondylitis	0.00031	0.00207	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00031	0.00207	CcSEcCtD
Levetiracetam—Mental disorder—Prednisone—ankylosing spondylitis	0.00031	0.00207	CcSEcCtD
Levetiracetam—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000308	0.00206	CcSEcCtD
Levetiracetam—Malnutrition—Prednisone—ankylosing spondylitis	0.000308	0.00205	CcSEcCtD
Levetiracetam—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000307	0.00205	CcSEcCtD
Levetiracetam—Convulsion—Dexamethasone—ankylosing spondylitis	0.000306	0.00204	CcSEcCtD
Levetiracetam—Convulsion—Betamethasone—ankylosing spondylitis	0.000306	0.00204	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000304	0.0107	CbGpPWpGaD
Levetiracetam—Myalgia—Dexamethasone—ankylosing spondylitis	0.000301	0.00201	CcSEcCtD
Levetiracetam—Myalgia—Betamethasone—ankylosing spondylitis	0.000301	0.00201	CcSEcCtD
Levetiracetam—Anxiety—Dexamethasone—ankylosing spondylitis	0.0003	0.002	CcSEcCtD
Levetiracetam—Anxiety—Betamethasone—ankylosing spondylitis	0.0003	0.002	CcSEcCtD
Levetiracetam—Pain—Prednisolone—ankylosing spondylitis	0.000295	0.00197	CcSEcCtD
Levetiracetam—Hepatitis—Methotrexate—ankylosing spondylitis	0.000295	0.00197	CcSEcCtD
Levetiracetam—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000293	0.00196	CcSEcCtD
Levetiracetam—Vision blurred—Prednisone—ankylosing spondylitis	0.00029	0.00194	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000289	0.00193	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000289	0.00193	CcSEcCtD
Levetiracetam—Insomnia—Triamcinolone—ankylosing spondylitis	0.000287	0.00192	CcSEcCtD
Levetiracetam—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000287	0.00191	CcSEcCtD
Levetiracetam—Infection—Dexamethasone—ankylosing spondylitis	0.000286	0.00191	CcSEcCtD
Levetiracetam—Infection—Betamethasone—ankylosing spondylitis	0.000286	0.00191	CcSEcCtD
Levetiracetam—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000285	0.00191	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000285	0.0019	CcSEcCtD
Levetiracetam—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000285	0.0019	CcSEcCtD
Levetiracetam—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000283	0.00189	CcSEcCtD
Levetiracetam—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000283	0.00189	CcSEcCtD
Levetiracetam—Agitation—Prednisone—ankylosing spondylitis	0.000283	0.00189	CcSEcCtD
Levetiracetam—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000282	0.00188	CcSEcCtD
Levetiracetam—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000282	0.00188	CcSEcCtD
Levetiracetam—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00028	0.00187	CcSEcCtD
Levetiracetam—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000279	0.00186	CcSEcCtD
Levetiracetam—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000279	0.00186	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	0.000278	0.00982	CbGpPWpGaD
Levetiracetam—Vertigo—Prednisone—ankylosing spondylitis	0.000276	0.00185	CcSEcCtD
Levetiracetam—Eye disorder—Methotrexate—ankylosing spondylitis	0.000276	0.00184	CcSEcCtD
Levetiracetam—Anorexia—Betamethasone—ankylosing spondylitis	0.000275	0.00184	CcSEcCtD
Levetiracetam—Anorexia—Dexamethasone—ankylosing spondylitis	0.000275	0.00184	CcSEcCtD
Levetiracetam—Fatigue—Triamcinolone—ankylosing spondylitis	0.000274	0.00183	CcSEcCtD
Levetiracetam—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000273	0.00183	CcSEcCtD
Levetiracetam—Pain—Triamcinolone—ankylosing spondylitis	0.000272	0.00181	CcSEcCtD
Levetiracetam—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000267	0.00178	CcSEcCtD
Levetiracetam—Convulsion—Prednisone—ankylosing spondylitis	0.000267	0.00178	CcSEcCtD
Levetiracetam—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000266	0.00178	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000263	0.00175	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000263	0.00175	CcSEcCtD
Levetiracetam—Myalgia—Prednisone—ankylosing spondylitis	0.000262	0.00175	CcSEcCtD
Levetiracetam—Arthralgia—Prednisone—ankylosing spondylitis	0.000262	0.00175	CcSEcCtD
Levetiracetam—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000262	0.00175	CcSEcCtD
Levetiracetam—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000261	0.00174	CcSEcCtD
Levetiracetam—Anxiety—Prednisone—ankylosing spondylitis	0.000261	0.00174	CcSEcCtD
Levetiracetam—Alopecia—Methotrexate—ankylosing spondylitis	0.000261	0.00174	CcSEcCtD
Levetiracetam—Insomnia—Dexamethasone—ankylosing spondylitis	0.000261	0.00174	CcSEcCtD
Levetiracetam—Insomnia—Betamethasone—ankylosing spondylitis	0.000261	0.00174	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00026	0.00174	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000259	0.00173	CcSEcCtD
Levetiracetam—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000259	0.00173	CcSEcCtD
Levetiracetam—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000259	0.00173	CcSEcCtD
Levetiracetam—Mental disorder—Methotrexate—ankylosing spondylitis	0.000259	0.00173	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	0.000259	0.00913	CbGpPWpGaD
Levetiracetam—Malnutrition—Methotrexate—ankylosing spondylitis	0.000257	0.00172	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000255	0.0017	CcSEcCtD
Levetiracetam—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000254	0.00169	CcSEcCtD
Levetiracetam—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000254	0.00169	CcSEcCtD
Levetiracetam—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000251	0.00168	CcSEcCtD
Levetiracetam—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000251	0.00167	CcSEcCtD
Levetiracetam—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000251	0.00167	CcSEcCtD
Levetiracetam—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000251	0.00167	CcSEcCtD
Levetiracetam—Infection—Prednisone—ankylosing spondylitis	0.000249	0.00167	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000249	0.00166	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000249	0.00166	CcSEcCtD
Levetiracetam—Back pain—Methotrexate—ankylosing spondylitis	0.000249	0.00166	CcSEcCtD
Levetiracetam—Fatigue—Dexamethasone—ankylosing spondylitis	0.000249	0.00166	CcSEcCtD
Levetiracetam—Fatigue—Betamethasone—ankylosing spondylitis	0.000249	0.00166	CcSEcCtD
Levetiracetam—Pain—Betamethasone—ankylosing spondylitis	0.000247	0.00165	CcSEcCtD
Levetiracetam—Pain—Dexamethasone—ankylosing spondylitis	0.000247	0.00165	CcSEcCtD
Levetiracetam—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000246	0.00164	CcSEcCtD
Levetiracetam—Skin disorder—Prednisone—ankylosing spondylitis	0.000244	0.00163	CcSEcCtD
Levetiracetam—Vision blurred—Methotrexate—ankylosing spondylitis	0.000242	0.00162	CcSEcCtD
Levetiracetam—Anorexia—Prednisone—ankylosing spondylitis	0.000239	0.0016	CcSEcCtD
Levetiracetam—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000238	0.00159	CcSEcCtD
Levetiracetam—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000238	0.00159	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000236	0.00157	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000236	0.00157	CcSEcCtD
Levetiracetam—SV2A—Disease—HLA-A—ankylosing spondylitis	0.000234	0.00827	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000234	0.00156	CcSEcCtD
Levetiracetam—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000234	0.00156	CcSEcCtD
Levetiracetam—Vertigo—Methotrexate—ankylosing spondylitis	0.000231	0.00154	CcSEcCtD
Levetiracetam—Leukopenia—Methotrexate—ankylosing spondylitis	0.00023	0.00154	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000229	0.00153	CcSEcCtD
Levetiracetam—Dizziness—Prednisolone—ankylosing spondylitis	0.000228	0.00153	CcSEcCtD
Levetiracetam—Asthenia—Triamcinolone—ankylosing spondylitis	0.000228	0.00152	CcSEcCtD
Levetiracetam—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000228	0.00152	CcSEcCtD
Levetiracetam—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000228	0.00152	CcSEcCtD
Levetiracetam—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000228	0.00152	CcSEcCtD
Levetiracetam—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000228	0.00152	CcSEcCtD
Levetiracetam—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000227	0.00152	CcSEcCtD
Levetiracetam—Insomnia—Prednisone—ankylosing spondylitis	0.000227	0.00152	CcSEcCtD
Levetiracetam—Paraesthesia—Prednisone—ankylosing spondylitis	0.000225	0.00151	CcSEcCtD
Levetiracetam—Pruritus—Triamcinolone—ankylosing spondylitis	0.000225	0.0015	CcSEcCtD
Levetiracetam—Cough—Methotrexate—ankylosing spondylitis	0.000224	0.0015	CcSEcCtD
Levetiracetam—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000224	0.0015	CcSEcCtD
Levetiracetam—Convulsion—Methotrexate—ankylosing spondylitis	0.000223	0.00149	CcSEcCtD
Levetiracetam—Dyspepsia—Prednisone—ankylosing spondylitis	0.000221	0.00148	CcSEcCtD
Levetiracetam—Chest pain—Methotrexate—ankylosing spondylitis	0.000219	0.00146	CcSEcCtD
Levetiracetam—Myalgia—Methotrexate—ankylosing spondylitis	0.000219	0.00146	CcSEcCtD
Levetiracetam—Arthralgia—Methotrexate—ankylosing spondylitis	0.000219	0.00146	CcSEcCtD
Levetiracetam—Decreased appetite—Prednisone—ankylosing spondylitis	0.000218	0.00146	CcSEcCtD
Levetiracetam—Rash—Prednisolone—ankylosing spondylitis	0.000218	0.00145	CcSEcCtD
Levetiracetam—Dermatitis—Prednisolone—ankylosing spondylitis	0.000218	0.00145	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000217	0.00145	CcSEcCtD
Levetiracetam—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000217	0.00145	CcSEcCtD
Levetiracetam—Fatigue—Prednisone—ankylosing spondylitis	0.000216	0.00145	CcSEcCtD
Levetiracetam—Headache—Prednisolone—ankylosing spondylitis	0.000216	0.00145	CcSEcCtD
Levetiracetam—Constipation—Prednisone—ankylosing spondylitis	0.000215	0.00143	CcSEcCtD
Levetiracetam—Confusional state—Methotrexate—ankylosing spondylitis	0.000212	0.00141	CcSEcCtD
Levetiracetam—Dizziness—Triamcinolone—ankylosing spondylitis	0.00021	0.0014	CcSEcCtD
Levetiracetam—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00021	0.0014	CcSEcCtD
Levetiracetam—Infection—Methotrexate—ankylosing spondylitis	0.000208	0.00139	CcSEcCtD
Levetiracetam—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000207	0.00138	CcSEcCtD
Levetiracetam—Asthenia—Dexamethasone—ankylosing spondylitis	0.000207	0.00138	CcSEcCtD
Levetiracetam—Asthenia—Betamethasone—ankylosing spondylitis	0.000207	0.00138	CcSEcCtD
Levetiracetam—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000206	0.00137	CcSEcCtD
Levetiracetam—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000205	0.00137	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000205	0.00137	CcSEcCtD
Levetiracetam—Nausea—Prednisolone—ankylosing spondylitis	0.000205	0.00137	CcSEcCtD
Levetiracetam—Pruritus—Dexamethasone—ankylosing spondylitis	0.000204	0.00136	CcSEcCtD
Levetiracetam—Pruritus—Betamethasone—ankylosing spondylitis	0.000204	0.00136	CcSEcCtD
Levetiracetam—Skin disorder—Methotrexate—ankylosing spondylitis	0.000204	0.00136	CcSEcCtD
Levetiracetam—Vomiting—Triamcinolone—ankylosing spondylitis	0.000202	0.00135	CcSEcCtD
Levetiracetam—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000202	0.00135	CcSEcCtD
Levetiracetam—Rash—Triamcinolone—ankylosing spondylitis	0.0002	0.00134	CcSEcCtD
Levetiracetam—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0002	0.00134	CcSEcCtD
Levetiracetam—Anorexia—Methotrexate—ankylosing spondylitis	0.0002	0.00134	CcSEcCtD
Levetiracetam—Rash—Methylprednisolone—ankylosing spondylitis	0.0002	0.00133	CcSEcCtD
Levetiracetam—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.0002	0.00133	CcSEcCtD
Levetiracetam—Headache—Triamcinolone—ankylosing spondylitis	0.000199	0.00133	CcSEcCtD
Levetiracetam—Headache—Methylprednisolone—ankylosing spondylitis	0.000199	0.00133	CcSEcCtD
Levetiracetam—Abdominal pain—Prednisone—ankylosing spondylitis	0.000198	0.00133	CcSEcCtD
Levetiracetam—Body temperature increased—Prednisone—ankylosing spondylitis	0.000198	0.00133	CcSEcCtD
Levetiracetam—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000197	0.00132	CcSEcCtD
Levetiracetam—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000197	0.00132	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000191	0.00128	CcSEcCtD
Levetiracetam—Dizziness—Dexamethasone—ankylosing spondylitis	0.000191	0.00127	CcSEcCtD
Levetiracetam—Dizziness—Betamethasone—ankylosing spondylitis	0.000191	0.00127	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	0.00019	0.00672	CbGpPWpGaD
Levetiracetam—Insomnia—Methotrexate—ankylosing spondylitis	0.00019	0.00127	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	0.000189	0.00668	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000189	0.00668	CbGpPWpGaD
Levetiracetam—Nausea—Triamcinolone—ankylosing spondylitis	0.000189	0.00126	CcSEcCtD
Levetiracetam—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000188	0.00126	CcSEcCtD
Levetiracetam—Nausea—Methylprednisolone—ankylosing spondylitis	0.000188	0.00126	CcSEcCtD
Levetiracetam—Somnolence—Methotrexate—ankylosing spondylitis	0.000187	0.00125	CcSEcCtD
Levetiracetam—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000185	0.00124	CcSEcCtD
Levetiracetam—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000185	0.00123	CcSEcCtD
Levetiracetam—Vomiting—Dexamethasone—ankylosing spondylitis	0.000183	0.00122	CcSEcCtD
Levetiracetam—Vomiting—Betamethasone—ankylosing spondylitis	0.000183	0.00122	CcSEcCtD
Levetiracetam—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000182	0.00122	CcSEcCtD
Levetiracetam—Rash—Dexamethasone—ankylosing spondylitis	0.000182	0.00121	CcSEcCtD
Levetiracetam—Rash—Betamethasone—ankylosing spondylitis	0.000182	0.00121	CcSEcCtD
Levetiracetam—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000182	0.00121	CcSEcCtD
Levetiracetam—Dermatitis—Betamethasone—ankylosing spondylitis	0.000182	0.00121	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000181	0.00121	CcSEcCtD
Levetiracetam—Fatigue—Methotrexate—ankylosing spondylitis	0.000181	0.00121	CcSEcCtD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000181	0.00638	CbGpPWpGaD
Levetiracetam—Headache—Dexamethasone—ankylosing spondylitis	0.000181	0.00121	CcSEcCtD
Levetiracetam—Headache—Betamethasone—ankylosing spondylitis	0.000181	0.00121	CcSEcCtD
Levetiracetam—Asthenia—Prednisone—ankylosing spondylitis	0.00018	0.0012	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	0.00018	0.00635	CbGpPWpGaD
Levetiracetam—Pain—Methotrexate—ankylosing spondylitis	0.000179	0.0012	CcSEcCtD
Levetiracetam—Pruritus—Prednisone—ankylosing spondylitis	0.000178	0.00119	CcSEcCtD
Levetiracetam—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000173	0.00115	CcSEcCtD
Levetiracetam—Diarrhoea—Prednisone—ankylosing spondylitis	0.000172	0.00115	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000172	0.00115	CcSEcCtD
Levetiracetam—Nausea—Dexamethasone—ankylosing spondylitis	0.000171	0.00114	CcSEcCtD
Levetiracetam—Nausea—Betamethasone—ankylosing spondylitis	0.000171	0.00114	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000167	0.00589	CbGpPWpGaD
Levetiracetam—Dizziness—Prednisone—ankylosing spondylitis	0.000166	0.00111	CcSEcCtD
Levetiracetam—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000166	0.00111	CcSEcCtD
Levetiracetam—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000166	0.00111	CcSEcCtD
Levetiracetam—Vomiting—Prednisone—ankylosing spondylitis	0.00016	0.00107	CcSEcCtD
Levetiracetam—Rash—Prednisone—ankylosing spondylitis	0.000158	0.00106	CcSEcCtD
Levetiracetam—Dermatitis—Prednisone—ankylosing spondylitis	0.000158	0.00106	CcSEcCtD
Levetiracetam—Headache—Prednisone—ankylosing spondylitis	0.000157	0.00105	CcSEcCtD
Levetiracetam—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000155	0.00103	CcSEcCtD
Levetiracetam—Asthenia—Methotrexate—ankylosing spondylitis	0.000151	0.00101	CcSEcCtD
Levetiracetam—Nausea—Prednisone—ankylosing spondylitis	0.000149	0.000996	CcSEcCtD
Levetiracetam—Pruritus—Methotrexate—ankylosing spondylitis	0.000148	0.000991	CcSEcCtD
Levetiracetam—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000144	0.000959	CcSEcCtD
Levetiracetam—Dizziness—Methotrexate—ankylosing spondylitis	0.000139	0.000927	CcSEcCtD
Levetiracetam—Vomiting—Methotrexate—ankylosing spondylitis	0.000133	0.000891	CcSEcCtD
Levetiracetam—Rash—Methotrexate—ankylosing spondylitis	0.000132	0.000883	CcSEcCtD
Levetiracetam—Dermatitis—Methotrexate—ankylosing spondylitis	0.000132	0.000883	CcSEcCtD
Levetiracetam—Headache—Methotrexate—ankylosing spondylitis	0.000131	0.000878	CcSEcCtD
Levetiracetam—Nausea—Methotrexate—ankylosing spondylitis	0.000125	0.000832	CcSEcCtD
Levetiracetam—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	7.2e-05	0.00254	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	3.78e-05	0.00133	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.55e-05	0.00125	CbGpPWpGaD
